NASDAQ: CADL · Biotechnology
Over the past week, Candel Therapeutics (CADL) drew about 31 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 39% bullish but is far apart: News runs 100% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 8 of 9 analysts rating CADL a buy.
There is little buzz around CADL this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 89% buy share sits next to a crowd that ranges from Reddit at 0% to News at 100%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Strong Buy: 8 buy calls against 0 sell, with an average 12-month price target of $21.75.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 50 points above the crowd average of 39%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Weekly price context: this Alpha Vantage chart keeps its own dated range; the sentiment metrics elsewhere on this page may be newer. Over the 30-day window, Candel Therapeutics (CADL) buzz held subdued around 28.1 while the price drifted down 15.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.2M shares. Updated Sep 26, 2026. Over the last 7 trading days, CADL lost 2.8%. Buzz activity in the recent week averaged 32.0 and was relatively stable, swinging between 24.2 and 39.6. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 7 of the 14 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CADL and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CADL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 28, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (8 / 1 / 0) |
| Crowd bullish (7d) | 39% |
| Avg price target | $21.75 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 100 pts |
| Mentions (7d) | 31 |
| Market cap | $883.8M |
| P/E · Forward P/E | n/a · 43.5 |
| EPS · Beta | -$1.51 · -0.5 |
| Revenue (TTM) | $31,000 · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Candel Therapeutics (CADL) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 39% bullish across 3 active sources. Those sources contribute 31 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Candel Therapeutics (CADL) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 4 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Candel Therapeutics (CADL), averaging 39% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 0%, a 100-point spread. On the professional side, 8 of 9 analysts rate CADL a buy.
Of the 9 analysts covering Candel Therapeutics (CADL), 8 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $21.75. That puts the street ahead of the crowd, which averages 39% bullish.
Candel Therapeutics (CADL)'s cross-source average is bearish at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 17% bullish, News reads 100% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Candel Therapeutics (CADL) at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 0% bullish. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 25 mentions (81% of total volume). X contributes 6 mentions. The cross-source average is bearish at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CADL's sell signal at 93/100 conviction reflects a bearish cross-source average at 39% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The CADL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key